Alpha 2.0
Login Register
» Authors » Adam Tepler

Adam Tepler

Explore the profile of Adam Tepler including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 68
Followers 0
Related Specialties
Gastroenterology
Pharmacology
Top 10 Co-Authors
Shailja C Shah
Neeraj Narula
Richard M Peek Jr
Jean-Frederic Colombel
Anish Patel
Gila Hoffman
Walter Reinisch
Samuel Sigal
Francesca Petralia
Giovanni Suarez
Published In
Clin Gastroenterol Hepatol
Gastroenterology
Aliment Pharmacol Ther
Nutr Res
Can J Gastroenterol Hepatol
Affiliations
Soon will be listed here.
Recent Articles
1.
Gender-Based Differences in Response to Tumor Necrosis Factor Inhibitor Therapies for Ulcerative Colitis: Individual Participant Data Meta-Analyses of Clinical Trials
Agrawal M, Petralia F, Tepler A, Durbin L, Reinisch W, Colombel J, et al.
Inflamm Bowel Dis . 2022 Apr; 29(1):1-8. PMID: 35366313
Background: Gender-based differences are reported in inflammatory bowel diseases (IBD) pathogenesis, but their impacts on IBD outcomes are not well known. We determined gender-based differences in response to treatment with...
2.
Intake of artificial sweeteners among adults is associated with reduced odds of gastrointestinal luminal cancers: a meta-analysis of cohort and case-control studies
Tepler A, Hoffman G, Jindal S, Narula N, Shah S
Nutr Res . 2021 Aug; 93:87-98. PMID: 34461350
The association between artificial sweetener (AS) consumption and the risk of organ-specific cancers has been debated for decades. We hypothesized that AS consumption is associated with reduced risk of gastrointestinal...
3.
Host Genetic Determinants Associated With Helicobacter pylori Eradication Treatment Failure: A Systematic Review and Meta-analysis
Shah S, Tepler A, Chung C, Suarez G, Peek Jr R, Hung A, et al.
Gastroenterology . 2021 Aug; 161(5):1443-1459. PMID: 34358488
Background & Aims: Helicobacter pylori infects approximately 50% of individuals worldwide. Successful H pylori eradication is associated with reduced risk of gastric cancer and peptic ulcer disease, among other conditions....
4.
Admission Serum Bicarbonate Predicts Adverse Clinical Outcomes in Hospitalized Cirrhotic Patients
Schopis M, Kumar A, Parides M, Tepler A, Sigal S
Can J Gastroenterol Hepatol . 2021 May; 2021:9915055. PMID: 34055676
A low serum bicarbonate (SB) level is predictive of adverse outcomes in kidney injury, infection, and aging. Because the liver plays an important role in acid-base homeostasis and lactic acid...
5.
Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease
Tepler A, Narula N, Peek Jr R, Patel A, Edelson C, Colombel J, et al.
Aliment Pharmacol Ther . 2019 Jun; 50(2):121-131. PMID: 31165513
Background: Accumulating data support a protective role of Helicobacter pylori against inflammatory bowel diseases (IBD), which might be mediated by strain-specific constituents, specifically cagA expression. Aim: To perform a systematic...
6.
Association Between Helicobacter pylori Exposure and Decreased Odds of Eosinophilic Esophagitis-A Systematic Review and Meta-analysis
Shah S, Tepler A, Peek Jr R, Colombel J, Hirano I, Narula N
Clin Gastroenterol Hepatol . 2019 Jan; 17(11):2185-2198.e3. PMID: 30659992
Background & Aims: Previous or current infection with Helicobacter pylori (exposure) has been reported to protect against eosinophilic esophagitis (EoE), perhaps owing to H pylori-induced immunomodulation. However, findings vary. We...